DS-1971a clinical trials
Also written DS-1971a.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses DS-1971a is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses DS-1971a is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971aCompletedPhase 1Daiichi SankyoNCT02261376Written as DS-1971a
- Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a TabletsCompletedPhase 1Daiichi SankyoNCT02266940Written as DS-1971a suspension
- Multiple Dose Study of DS-1971aCompletedPhase 1Daiichi SankyoNCT02190058Written as DS-1971a
- Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.CompletedPhase 1Daiichi SankyoNCT02107885Written as DS-1971
- Multiple Dose Study of D1971a in Healthy VolunteersCompletedPhase 1Daiichi SankyoNCT02564861Written as DS-1971a
- Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)WithdrawnPhase 2Daiichi SankyoNCT02673866Written as DS-1971a
- A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTSCompletedPhase 1Daiichi SankyoNCT02473627Written as DS-1971a
Codes
What other systems call DS-1971a · ClinicalTrials.gg INT001503
- MeSH (NLM) C000712258DS-1971aOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000712258 | DS-1971a | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.